Medicinal – Page 173

Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study

mycolabadmin

Fungal infections are a serious hidden threat in hospital intensive care units, particularly for patients with weakened immune systems. This study establishes India’s first comprehensive database system to track fungal infections across 8 major medical centers nationwide. By collecting detailed information about these infections and how they respond to treatments, the research aims to help doctors diagnose and treat fungal infections faster and more effectively. The findings will guide better clinical practices and public health policies to combat these often-neglected but deadly infections.

Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers

mycolabadmin

This study evaluated how well different blood tests can detect histoplasmosis, a serious fungal infection caused by Histoplasma capsulatum. Researchers compared three types of tests: those detecting fungal antigens, those detecting antibodies the body produces against the fungus, and DNA-based tests. They found that the best test depends on whether the patient’s immune system is functioning normally or is weakened by HIV, and using a combination of tests provides the most reliable diagnosis. The study also identified specific immune markers in the blood that are elevated in infected patients, which could help predict disease severity.

Bioactivity and chemical screening of endophytic fungi associated with seaweeds Gracilaria sp. and Sargassum sp. of the Bay of Bengal, Bangladesh

mycolabadmin

Researchers discovered several types of fungi living inside seaweed from Bangladesh’s Bay of Bengal coast. These fungi produce natural compounds that can fight bacteria, reduce harmful oxidative damage, and potentially kill cancer cells. The study identified specific chemical compounds responsible for these beneficial properties, suggesting these fungi could be useful sources for developing new medicines.

Graphene nanomaterials: A new frontier in preventing respiratory fungal infections

mycolabadmin

Scientists are exploring nano-graphene oxide, a microscopic material made from graphene, as a new treatment for serious lung fungal infections. These tiny particles can kill fungal cells through multiple mechanisms and deliver antifungal drugs directly to infection sites while reducing harmful side effects. Researchers found that graphene oxide can be combined with existing antifungal medications to make them work better and even help overcome drug-resistant fungal infections.

Exploring the Anticancer Potential of Coriolus versicolor in Breast Cancer: A Review

mycolabadmin

Coriolus versicolor, also known as turkey tail mushroom, has been used in traditional Chinese medicine for thousands of years. Recent scientific research shows it may help fight breast cancer through multiple mechanisms: killing cancer cells directly through programmed cell death pathways, breaking down the estrogen that fuels some breast cancers, preventing cancer spread, and boosting the immune system. While early studies are promising and one clinical trial showed good safety and immune benefits, larger studies are needed before this mushroom can be recommended as an official cancer treatment.

Clinical characterization of immunocompetent patients with Scedosporium detected in respiratory samples: A case series

mycolabadmin

This study examined eight elderly patients without compromised immune systems who had Scedosporium fungus detected in their lungs. All patients had a condition called bronchiectasis and most had previously suffered from a lung infection called MAC disease. The researchers found that in most cases, the fungus was simply living in the lungs without causing active infection, though distinguishing between these two situations proved difficult. Only one patient was diagnosed with an active Scedosporium infection and required antifungal treatment with a drug called voriconazole.

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists discovered a special bacterium called Streptomyces formicae living in ant nests in Africa that produces powerful antibiotics effective against dangerous drug-resistant bacteria and fungi. This bacterium has the genetic potential to make at least 45 different antimicrobial compounds, though most are not currently being produced under standard laboratory conditions. Using advanced gene-editing techniques like CRISPR, researchers are working to activate these hidden pathways to discover new medicines. This research demonstrates how exploring bacteria in nature can lead to finding new antibiotics to treat serious infections.

Geotrichosis Due to Magnusiomyces capitatus: A Severe Emerging Invasive Fungal Disease

mycolabadmin

A 71-year-old cancer patient receiving chemotherapy developed a severe blood infection caused by a rare fungus called Magnusiomyces capitatus. This emerging fungal infection caused septic shock and multiple organ failure despite treatment with antifungal medications. The case highlights how these rare fungi can be deadly in patients with weakened immune systems and emphasizes the importance of quick, accurate identification using advanced laboratory techniques to guide treatment decisions.

Identification, characterization, antimicrobial activity and biocontrol potential of four endophytic fungi isolated from Amazonian plants

mycolabadmin

Scientists isolated four types of fungi living inside the leaves of medicinal plants from the Amazon region of Bolivia. These fungi produce natural compounds that kill harmful bacteria and fungi that damage potato crops. The findings show promise for developing natural alternatives to synthetic pesticides and antibiotics for agricultural and medical applications.

The First Whole Genome Sequence and Methylation Profile of Gerronema lapidescens QL01

mycolabadmin

Researchers sequenced the complete genome of Lei Wan (Gerronema lapidescens), a medicinal mushroom used in Chinese traditional medicine for treating parasites and digestive issues. The study reveals the mushroom’s genetic makeup, including 15,847 genes and over 3 million methylation marks that may control gene expression. They identified 67 gene clusters that could produce medicinal compounds and 521 enzymes for breaking down organic matter. This genetic blueprint will help scientists understand how to cultivate this threatened species sustainably and develop its health benefits.

Research Topic: Medicinal